Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer sells further shares in Sensodyne maker Haleon
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Pfizer sells stake in Sensodyne and Panadol maker Haleon worth around £2.4bn
Pfizer sold 640 million shares in Haleon for 380p each, reducing its holding in the consumer healthcare firm by 7.6%
Pfizer to Sell About $3.25 Billion Stake in Sensodyne-Maker Haleon, Bookrunner Says
(Reuters) - Pfizer intends to offload about 540 million shares in the British consumer healthcare company Haleon, a bookrunner said on Monday. The proposed sale will reduce the top shareholder's interest in Sensodyne-maker Haleon to 16.2% from 22.6%.
Pfizer to offload about 6% stake in Sensodyne-maker Haleon
Pfizer intends to sell about 540 million shares in British consumer healthcare company Haleon, a bookrunner said on Monday, reducing the top shareholder's
Pfizer to Pare Back Haleon Stake With 540 Million Share Offering
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health giant.
Drug giant Pfizer sells $3.3 billion stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Pfizer sells $3.3 billion stake in Sensodyne-maker Haleon
Pfizer has sold a stake in British consumer healthcare group Haleon worth about $3.26 billion, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Pfizer to Receive 2.66 Billion Pounds From Haleon in Share Deal
Pfizer will receive around 2.66 billion pounds ($3.56 billion) in aggregate from Haleon from an offering and a share buyback. Goldman Sachs International said Tuesday that the pharmaceutical company sold 640 million ordinary shares in British consumer-healthcare business Haleon at 380 pence a share.
Pfizer Sells $3.26B Stake in Haleon
Pfizer Inc. ($PFE) has sold its stake worth $3.26 billion in UK-based consumer healthcare company Haleon PLC ($GB:HLN). With this transaction,
Pfizer cuts Haleon stake in $3.3B share sale
Pfizer (PFE) reduces its stake in Haleon to 15% from 22.6% by selling £2.45B worth of shares, continuing its gradual divestment strategy. Read more here.
Haleon buys back £230m of its shares as Pfizer sells down stake
Haleon said Pfizer's stake was expected to fall to 15 per cent from 22.6 per cent. Haleon shares fell 0.25 per cent or 1.00p to 391.90p, having risen around 15 per cent in the las
FiercePharma
1d
Pfizer gins up £2.4B after unloading hundreds of millions of Haleon shares
Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...
2d
on MSN
Pfizer to offload about 5.9% stake in UK's Haleon, says bookrunner
Pfizer intends to offload about 540 million shares in the British consumer healthcare company Haleon, a bookrunner said on ...
2d
Pfizer Raises $3.2 Billion by Selling Part of Haleon Stake
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health ...
1d
Pfizer's Total Interest In Haleon To Reduce From Approx. 22.6% To Approx. 15.0%
Pfizer said, further to the Launch Announcement on 30 September 2024, it has sold 640 million ordinary shares in Haleon plc, at a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Sensodyne
GlaxoSmithKline
Feedback